ALFASIGMA S.p.A. (manufacturing of finished dosage form, primary and secondary packaging, quality control and batch release)

The drug is prescribed for adults and children (including newborns) to treat severe infections caused by certain Gram-negative bacteria. It is also used via inhalation for the treatment of chronic pulmonary infections in patients with cystic fibrosis.

Dosage form: powder for solution for injection or inhalation

ATC: J01XB01